In the present study, we used real-time confocal imaging to examine the effect of salbutamol, a b 2 -adrenoceptor agonist, on the dynamic [Ca 21 ] i responses of porcine ASM cells to ACh. Using oscillation amplitude, rise time, fall time, and frequency as parameters, we attempted to elucidate the mechanisms by which salbutamol reduces [Ca 21 ] i levels.
ELEVATION OF INTRACELLULAR Ca 21 concentration ([Ca
] i ) plays an important role in the development and maintenance of force in airway smooth muscle (ASM) cells (27) 21 release from the sarcoplasmic reticulum (SR) (4, 20) , promote Ca 21 reuptake (5, 17) , promote Ca 21 efflux (3, 6, 15, 31) , and/or inhibit Ca 21 influx (4, 26) . Adenosine 38,58-cyclic monophosphate (cAMP)-dependent hyperpolarization and consequent reduction of Ca 21 influx via activation of large-conductance Ca 21 -activated K 1 (BK Ca ) channels have also been demonstrated (16, 24) .
In recent studies, we (13, 23) and others (18) 21 ] i oscillations have also been previously reported in vascular (2, 7, 9, 21) and gastric smooth muscle cells (19) . Nuttle and Farley (22) recently reported that isoproterenol, a b-adrenoceptor agonist, modulates the frequency of ACh-induced [Ca 21 ] i oscillations in porcine ASM cells. These investigators proposed that the inhibition of [Ca 21 ] i oscillations by b-adrenoceptor agonists involved reduced Ca 21 influx. However, given the fact that b-adrenoceptor agonists also affect other Ca 21 regulatory sites, modulation of [Ca 21 ] i oscillations by these agonists might also involve additional mechanisms such as reduced Ca 21 release, increased reuptake, and enhanced efflux.
In the present study, we used real-time confocal imaging to examine the effect of salbutamol, a b 2 -adrenoceptor agonist, on the dynamic [Ca 21 ] i responses of porcine ASM cells to ACh. Using oscillation amplitude, rise time, fall time, and frequency as parameters, we attempted to elucidate the mechanisms by which salbutamol reduces [Ca 21 ] i levels.
METHODS
Cell preparation. Porcine trachea were obtained from a local abattoir. The techniques for dissociation of ASM cells have been published previously (11, 12) . Briefly, the smooth muscle layer was excised, freed of epithelium, and minced thoroughly in Hanks' balanced salt solution (HBSS) buffered with 10 mM N-2-hydroxyethylpiperazine-N8-2-ethanesulfonic acid (pH 7.4; GIBCO-BRL). ASM cells were dissociated by incubating the tissue with 20 U/ml papain, 2,000 U/ml deoxyribonuclease (Worthington Biochemical), and 1 mg/ml type IV collagenase (Worthington Biochemical). The dissociated cells were then triturated, centrifuged, and resuspended in minimum essential medium with 10% fetal calf serum. The ASM cells were plated on collagen-coated glass coverslips. Trypan blue exclusion was used to assess cell viability (.90% of all cells).
The cells were loaded for 30-45 min at 37°C with 5 µM fluo-3 acetoxymethyl ester (Molecular Probes). The coverslip was then washed in HBSS, mounted on an open microscope slide chamber (RC-25F, Warner Instruments), and perfused at 2-3 ml/min at room temperature.
Real-time confocal imaging. Detailed descriptions of the confocal imaging technique have been recently published (23) . An Odyssey XL real-time confocal system (Noran Instruments, Middleton, WI) equipped with an Ar-Kr laser (488-nm line) and mounted on the Nikon microscope was used to visualize fluo-3-loaded ASM cells. The system was controlled through a Silicon Graphics Indy workstation. A Nikon 340/ 1.3 oil-immersion objective lens was used, and image size was set to 640 3 480 pixels, with a calibrated pixel area of 0.063 µm 2 /pixel. Only one fixed combination of laser intensity (20% of maximum) and photomultiplier gain (1,800 of a maximum of 4,096) was used. At this setting, pixel intensities within regions of interest (ROI) ranged between 25 and 255 gray levels (GL). Fluorescence bleaching was found to be ,25% across a 20-min period. However, all experimental protocols were limited to ,5 min of continued laser exposure. ROI with a fixed dimension of 5 3 5 pixels (1.5 µm 2 ) were drawn within cell boundaries. The optical section thickness for the 340 lens was set to 1 µm by controlling the confocal slit size. Therefore, [Ca 21 ] i measurements were obtained from a volume of 1.5 µm 3 .
The confocal system is capable of acquiring 480 frames/s. In preliminary studies on fluo-3-loaded ASM cells, we determined that an acquisition rate of 30 21 ] i oscillations also remained relatively constant during this steady-state period for as long as the cells were exposed to ACh.
After a steady state was reached, the cells were sequentially exposed to 1 nM, 10 nM, 100 nM, and 1 µM salbutamol (Glaxo-Wellcome) in the continued presence of ACh. Each exposure of salbutamol was maintained for 2 min and was followed by a wash in 1 µM ACh for 2 min. Other ASM cells were continuously exposed to 1 µM ACh for 20 min, and the [Ca 21 ] i response was evaluated. During periods of equilibration and washing, the cells were not exposed to the laser.
On the basis of the results of this protocol, it was determined that the maximal effect of salbutamol on the [Ca 21 ] i response occurred at a concentration of 1 µM. Accordingly, a fixed concentration of 1 µM salbutamol was used in subsequent protocols.
Effect of salbutamol on Ca 21 influx. ASM cells were exposed to 1 µM ACh to induce [Ca 21 ] i oscillations. After a steady state was reached, the cells were exposed to 100 nM BAY K 8644, to promote Ca 21 influx through voltage-gated membrane channels. The effect of 1 µM salbutamol was then evaluated. Another group of ASM cells was preexposed to 10 nM charybdotoxin, a selective inhibitor of BK Ca channels. The cells were then exposed to 1 µM ACh and subsequently to 1 µM salbutamol.
Effect of salbutamol on SR Ca 21 release. ASM cells were preexposed to 1 µM salbutamol and subsequently to 5 mM caffeine to induce SR Ca 21 release from ryanodine receptor (RyR) channels (28) . In a second set of experiments, ASM cells were preexposed to Ca 21 -free HBSS and to 1 mM lanthanum to block both Ca 21 influx and efflux, respectively. The cells were then exposed to 1 µM ACh and subsequently to 1 µM salbutamol.
Effect of salbutamol on Ca 21 21 ] i oscillations, and after a steady state was reached, the cells were exposed to 500 µM 8-bromoadenosine 3,8,58-cyclic monophosphate (8-BrcAMP), a membranepermeant analog of cAMP.
Data analysis. Each cell was exposed to only one experimental protocol. At least five cells were chosen from each coverslip. Overall, 280 cells were analyzed. Dose-dependence data were compared by using a one-way analysis of variance with salbutamol concentration (a concentration of 0 was treated as control) as the grouping variable. Other data were compared by using t-tests. Bonferroni corrections were applied for repeated comparisons. Statistical significance was tested at a 0.05 level. Data are reported as means 6 SE. 21 (Fig. 4A) . Preexposure of ASM cells to 21 ] i oscillations that were sustained ( Fig. 4C; n 5 16 ). Further exposure of these ASM cells to 1 µM salbutamol had no effect on the amplitude or frequency of ongoing [Ca 21 ] i oscillations (Fig. 4C) .
RESULTS

Effect of salbutamol on ACh-induced [Ca
Effect (Fig. 5A) . In another group of ASM cells, ACh-induced [Ca 21 ] i oscillations were not inhibited by exposure to Ca 21 -free HBSS and thapsigargin when lanthanum was also present to block Ca 21 efflux (Fig. 5B; n 5 19) (2, 7, 9) , colonic smooth muscle (19) , uterine smooth muscle (14) , and more recent studies using porcine ASM cells (13, 18, 22, 23 Relaxation of smooth muscle by b-adrenoceptor stimulation is thought to be achieved by cyclic nucleotidedependent and -independent activation of BK Ca channels (16, 24) . Specific blockers of BK Ca channels, such as charybdotoxin, have been shown to inhibit the relaxation induced by b-adrenoceptor agonists (8, 10 21 would itself lead to an inhibition of oscillations (18, 23) , and thapsigargin also leads to an elevation of [Ca 21 ] i and inhibition of oscillations. Nonetheless, the fact that salbutamol had no effect on the stable AChinduced oscillations, under conditions where Ca 21 influx and efflux were both blocked by the combination of zero extracellular Ca 21 and lanthanum, clearly demonstrates that salbutamol primarily affects Ca 21 flux across the cell membrane. Enhancement of Ca 21 efflux may be achieved by modulation of the Na 1 /Ca 21 exchanger or by enhanced activity of the plasma membrane adenosinetriphosphatase pump.
Salbutamol did not appear to have any significant effect on SR Ca 21 release. In the present study, we did not specifically examine SR Ca 21 release through both IP 3 receptor and RyR channels. The data obtained by using caffeine suggest that Ca 21 release through RyR is unaffected. However, the fact that, when Ca 21 flux across the membrane was blocked by zero extracellular Ca 21 and lanthanum, salbutamol had no effect on ongoing ACh-induced [Ca 21 ] i oscillations would suggest that SR Ca 21 release is not significantly affected by b-adrenoceptors. In the present study, we observed that the fall time of ACh-induced oscillations, normalized for amplitude, was prolonged by exposure to salbutamol. This would suggest a partial inhibition of Ca 21 reuptake. Previous studies have suggested that b-adrenoceptor-agonist stimulation actually increases SR Ca 21 reuptake via a cAMP-mediated pathway. This would lead to an increase in oscillation frequency, which was not observed. Therefore, the results of the present study on oscillation fall time must be interpreted with caution. Because Ca 21 reuptake is directly correlated to basal [Ca 21 ] i , the prolongation of fall time with salbutamol exposure may be related to the reduction in basal [Ca 21 ] i .
In conclusion, the results of the present study indicate that increased b-adrenoceptor-agonist stimulation in ASM cells inhibits [Ca 21 ] i oscillations in a dosedependent fashion by decreasing basal Ca 21 levels. This decrease in basal Ca 21 may be achieved by modulating Ca 21 flux across the cell membrane.
